Cambridge Nutritional Sciences plc (FRA:RVKA)
Germany flag Germany · Delayed Price · Currency is EUR
0.0170
0.00 (0.00%)
Last updated: Nov 27, 2025, 9:59 AM CET

FRA:RVKA Statistics

Total Valuation

FRA:RVKA has a market cap or net worth of EUR 6.09 million. The enterprise value is 2.27 million.

Market Cap6.09M
Enterprise Value 2.27M

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date Nov 21, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 237.95M
Shares Outstanding n/a
Shares Change (YoY) +0.08%
Shares Change (QoQ) -0.13%
Owned by Insiders (%) 0.68%
Owned by Institutions (%) 83.62%
Float 194.38M

Valuation Ratios

The trailing PE ratio is 3.89.

PE Ratio 3.89
Forward PE n/a
PS Ratio 0.66
PB Ratio 0.48
P/TBV Ratio 0.70
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 1.45
EV / Sales 0.25
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -3.66

Financial Position

The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.02.

Current Ratio 4.25
Quick Ratio 3.79
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.44
Interest Coverage -36.00

Financial Efficiency

Return on equity (ROE) is 13.26% and return on invested capital (ROIC) is -3.23%.

Return on Equity (ROE) 13.26%
Return on Assets (ROA) -2.58%
Return on Invested Capital (ROIC) -3.23%
Return on Capital Employed (ROCE) -4.85%
Revenue Per Employee 109,915
Profits Per Employee 18,617
Employee Count84
Asset Turnover 0.62
Inventory Turnover 3.59

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -39.29% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -39.29%
50-Day Moving Average 0.02
200-Day Moving Average 0.03
Relative Strength Index (RSI) 15.79
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:RVKA had revenue of EUR 9.23 million and earned 1.56 million in profits. Earnings per share was 0.01.

Revenue9.23M
Gross Profit 6.13M
Operating Income -618,655
Pretax Income 1.56M
Net Income 1.56M
EBITDA -373,484
EBIT -618,655
Earnings Per Share (EPS) 0.01
Full Income Statement

Balance Sheet

The company has 4.12 million in cash and 271,521 in debt, giving a net cash position of 3.85 million.

Cash & Cash Equivalents 4.12M
Total Debt 271,521
Net Cash 3.85M
Net Cash Per Share n/a
Equity (Book Value) 12.67M
Book Value Per Share 0.05
Working Capital 5.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -309,327 and capital expenditures -310,473, giving a free cash flow of -619,800.

Operating Cash Flow -309,327
Capital Expenditures -310,473
Free Cash Flow -619,800
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 66.44%, with operating and profit margins of -6.70% and 16.94%.

Gross Margin 66.44%
Operating Margin -6.70%
Pretax Margin 16.94%
Profit Margin 16.94%
EBITDA Margin -4.05%
EBIT Margin -6.70%
FCF Margin n/a

Dividends & Yields

FRA:RVKA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.08%
Shareholder Yield -0.08%
Earnings Yield 25.68%
FCF Yield -10.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:RVKA has an Altman Z-Score of 1.14 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.14
Piotroski F-Score 4